Cathay Biotech Inc (688065) — Cash Flow Quality Index
Cathay Biotech Inc (688065) has a Cash Flow Quality Index of -0.47x as of September 2025. Operating cash flow of CN¥-66.22 Million is below net income of CN¥142.01 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Cathay Biotech Inc (688065) cash conversion ratio to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cathay Biotech Inc Cash Flow Quality Index (2016–2024)
Historical Cash Flow Quality Index for Cathay Biotech Inc across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check cash flow reinvestment rate of Cathay Biotech Inc to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Cathay Biotech Inc (2016–2024)
Year-by-year earnings quality comparison for Cathay Biotech Inc. For live market cap and the full company financial profile, see market cap of Cathay Biotech Inc.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.73x | CN¥820.93 Million | CN¥474.59 Million | ▲ +11.3% |
| 2023 | 1.55x | CN¥569.45 Million | CN¥366.52 Million | ▲ +18.4% |
| 2022 | 1.31x | CN¥803.67 Million | CN¥612.65 Million | ▲ +42.8% |
| 2021 | 0.92x | CN¥594.18 Million | CN¥646.68 Million | ▼ -18.4% |
| 2020 | 1.13x | CN¥514.96 Million | CN¥457.34 Million | ▲ +49.9% |
| 2019 | 0.75x | CN¥359.62 Million | CN¥478.88 Million | ▲ +3504.1% |
| 2018 | -0.02x | CN¥-10.29 Million | CN¥466.29 Million | ▼ -113.7% |
| 2017 | 0.16x | CN¥53.45 Million | CN¥332.73 Million | ▲ +118.2% |
| 2016 | -0.88x | CN¥-128.67 Million | CN¥145.47 Million | — |